Skip to content

Supplier News

Gilead closes deal to acquire Pharmasset

Gilead Sciences Inc. has completed its acquisition of Pharmasset Inc., a clinical-stage pharmaceutical firm. Gilead said late Tuesday that its subsidiary, Royal Merger Sub II Inc., has finalized the transaction to buy Pharmasset for $137 per share in cash, or about $11.2 billion.

GE, Bionime partner on blood glucose meter

GE Healthcare has entered into a global licensing pact with medical testing product specialist Bionime Corp. to provide new GE-branded solutions for the diabetes market. The GE100 Blood Glucose Monitoring System is the lead-off product in the GE-Bionime partnership. The General Electric Co.

Novo Nordisk, cooking star team on diabetes campaign

Novo Nordisk has partnered with celebrity cooks Paula Deen and her sons Bobby and Jamie Deen to launch "Diabetes in a New Light," a national effort to help adults find simple ways to manage type 2 diabetes. Celebrity cook Paula Deen with her sons Jamie (left) and Bobby. The diabetes care company

Roche to ship Accu-Chek Nano SmartView glucose meter

By the middle of this year, Roche Diabetes Care plans to release the Accu-Chek Nano SmartView, a miniature blood glucose monitor that the company said marks the brand’s first single-strip no-code meter. Accu-Chek Nano SmartView The company said this week that it received clearance from the U.S.

Shire acquires U.S. rights to Resolor

Shire PLC has acquired the rights to develop and market the gastrointestinal drug Resolor in the United States in an agreement with Janssen Pharmaceutica N.V. Shire said Tuesday that under the terms of the agreement, the U.S. rights to the Resolor trademark will be transferred to the company.

Catalina Marketing names former Dell exec as CIO

Catalina Marketing Corp. has appointed John Miles as its new executive vice president and chief information officer. The marketing specialist said Monday that in the CIO role, Miles will be responsible for leading IT strategy, research and development, and new product development.